tiprankstipranks
Trending News
More News >
Fineotex Chemical Limited (IN:FCL)
:FCL
India Market

Fineotex Chemical Limited (FCL) AI Stock Analysis

Compare
5 Followers

Top Page

IN:FCL

Fineotex Chemical Limited

(FCL)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
₹29.00
▲(18.42% Upside)
Fineotex Chemical Limited's strong financial performance is the primary driver of its stock score, supported by stable profitability and growth metrics. Technical analysis suggests a neutral trend with potential bullish momentum. The valuation indicates moderate overvaluation, which slightly tempers the overall score.
Positive Factors
Strong Financial Health
The company's robust profitability and stable balance sheet with low leverage highlight its strong financial position, supporting long-term growth and resilience.
Stable Balance Sheet
A strong balance sheet with low debt and high equity provides financial stability, enabling the company to withstand economic fluctuations and invest in growth opportunities.
Efficient Cost Management
Efficient cost management, reflected in strong and improving profit margins, enhances profitability and competitive positioning, supporting sustainable growth.
Negative Factors
Revenue Decline
A recent decline in revenue could indicate market challenges or competitive pressures, potentially impacting future growth if not addressed.
Cash Flow Variability
Fluctuating cash flow, particularly a decline in free cash flow, may pose liquidity challenges, affecting the company's ability to fund operations and investments.
Lower Cash Reserves
Reduced cash reserves can limit financial flexibility and increase vulnerability to unexpected expenses or downturns, necessitating prudent cash management.

Fineotex Chemical Limited (FCL) vs. iShares MSCI India ETF (INDA)

Fineotex Chemical Limited Business Overview & Revenue Model

Company DescriptionFineotex Chemical Limited manufactures and sells textile chemicals, and auxiliary and specialty chemicals in India and internationally. The company provides specialty textile chemicals for pretreatment, dyeing, printing, and finishing processes; water treatment chemicals, paper adhesives, and defoamers; various chemicals, such as benzalkonium chloride (BKC), barite, hematite, magnesium chloride, and calcium chloride; water-based drilling fluid chemicals, including clay/shale inhibitors, lubricants, specialty chemicals, spotting fluids, and loss circulation additives, as well as oil-based drilling fluid chemicals. It also offers cleaning, and hygiene products comprising liquid detergents, surface and hand disinfectants, sanitizing tablets, hand sanitizers and wash liquids, multi surface disinfectant liquids, and air fresheners; and white phenyl and detergent cakes. The company's products are used in textile, home care, hygiene, mining, garment, water treatment, leather, construction, paint, agrochemicals, and adhesives sectors. Fineotex Chemical Limited was founded in 1979 and is headquartered in Mumbai, India.
How the Company Makes MoneyFineotex Chemical Limited generates revenue through the production and sale of its specialty chemical products to various sectors, primarily focusing on textiles, detergents, and leather processing. The company's revenue model is built on direct sales to manufacturers and distributors who require high-quality chemical solutions. Key revenue streams include the sale of textile auxiliaries, surfactants, and other related chemicals, which are essential for enhancing the performance of textiles and materials. FCL also benefits from strategic partnerships with international clients and suppliers, enabling it to expand its market reach and enhance its product offerings. The company's focus on research and development fosters innovation in its product lines, contributing to customer loyalty and repeat business. Additionally, its commitment to sustainability and eco-friendly products attracts environmentally conscious consumers and businesses, further bolstering its revenue potential.

Fineotex Chemical Limited Financial Statement Overview

Summary
Fineotex Chemical Limited exhibits strong financial health with robust revenue growth, solid profitability, and a stable balance sheet characterized by low leverage. However, recent fluctuations in cash flow due to increased capital expenditures suggest a need for careful cash management.
Income Statement
Fineotex Chemical Limited has demonstrated robust revenue growth with a significant increase from 2020 to 2025. The company maintained a strong gross profit margin, consistently above 30%, and an improving net profit margin, indicating efficient cost management. Despite a slight dip in revenue in the latest year, the overall performance showcases resilience and profitability, making the income statement solid.
Balance Sheet
The balance sheet of Fineotex Chemical Limited reflects a healthy financial position with low debt levels and a growing stockholders' equity, resulting in a very low debt-to-equity ratio. The equity ratio remains strong, highlighting financial stability. However, the lower cash reserves in the latest year could pose a risk if not managed carefully.
Cash Flow
Cash flow analysis shows variability, with a recent decline in free cash flow due to increased capital expenditures. The operating cash flow to net income ratio indicates strong cash generation capabilities, although the fluctuation in free cash flow suggests potential liquidity challenges if investment activities continue to rise.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.29B5.33B5.69B5.17B3.67B2.17B
Gross Profit1.97B2.06B2.17B1.78B1.30B757.73M
EBITDA1.46B1.52B1.65B1.13B767.24M580.62M
Net Income1.04B1.08B1.20B883.16M551.74M425.88M
Balance Sheet
Total Assets0.008.15B5.48B4.22B3.39B2.67B
Cash, Cash Equivalents and Short-Term Investments416.97M330.01M735.06M611.90M308.35M279.33M
Total Debt0.002.17M51.90M72.80M19.08M34.76M
Total Liabilities-7.39B757.59M945.90M659.02M700.96M509.90M
Stockholders Equity7.39B7.31B4.47B3.49B2.62B2.09B
Cash Flow
Free Cash Flow0.00-73.46M494.76M887.62M-91.37M-149.48M
Operating Cash Flow0.00693.34M973.81M1.08B133.75M92.59M
Investing Cash Flow0.00-2.73B-468.50M-1.03B-7.44M-65.32M
Financing Cash Flow0.001.76B-239.11M-64.39M-56.59M-44.42M

Fineotex Chemical Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price24.49
Price Trends
50DMA
24.98
Negative
100DMA
24.65
Negative
200DMA
24.92
Negative
Market Momentum
MACD
-0.22
Positive
RSI
36.50
Neutral
STOCH
15.44
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FCL, the sentiment is Negative. The current price of 24.49 is above the 20-day moving average (MA) of 24.36, below the 50-day MA of 24.98, and below the 200-day MA of 24.92, indicating a bearish trend. The MACD of -0.22 indicates Positive momentum. The RSI at 36.50 is Neutral, neither overbought nor oversold. The STOCH value of 15.44 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FCL.

Fineotex Chemical Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
₹26.65B27.170.65%-10.12%-22.38%
74
Outperform
₹26.36B14.1510.26%46.49%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
₹27.34B38.020.39%19.75%13.42%
60
Neutral
₹29.80B22.70-22.04%-58.81%
45
Neutral
₹15.27B38.49
41
Neutral
₹25.90B-15.150.43%-11.11%-340.74%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:FCL
Fineotex Chemical Limited
23.26
-4.59
-16.48%
IN:KIRIINDUS
Kiri Industries Limited
496.50
-73.05
-12.83%
IN:MANINDS
Man Industries (India) Limited
351.45
41.85
13.52%
IN:MOL
Meghmani Organics Limited
60.04
-13.71
-18.59%
IN:RAMRAT
Ram Ratna Wires Limited
292.90
40.43
16.01%
IN:TIRUMALCHM
Thirumalai Chemicals Limited
218.25
-75.90
-25.80%

Fineotex Chemical Limited Corporate Events

Fineotex Chemical Files SEBI Demat Compliance Certificate for December 2025 Quarter
Jan 10, 2026

Fineotex Chemical Limited has submitted to the stock exchanges a compliance certificate from its registrar and share transfer agent, Bigshare Services Pvt. Ltd., confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025. The certificate states that all securities received for dematerialisation during the quarter were duly verified, either accepted or rejected, appropriately mutilated and cancelled where required, and that the depositories were recorded as the registered owners within the prescribed 15-day timeline, underscoring the company’s ongoing compliance with regulatory requirements in handling its listed securities.

Fineotex Chemical Limited Acquires U.S. Specialty Oilfield Chemicals Group
Dec 16, 2025

Fineotex Chemical Limited announced a strategic acquisition of CrudeChem Technologies, a leading U.S. specialty oilfield chemicals group. This move is expected to enhance Fineotex’s market positioning in the oilfield chemicals sector, potentially expanding its global footprint and offering new growth opportunities for stakeholders.

Fineotex Chemical Expands with U.S. Oilfield Chemicals Acquisition
Dec 10, 2025

Fineotex Chemical Limited announced the availability of an audio recording from an investor and analyst call discussing its recent acquisition of a leading U.S. specialty oilfield chemicals group. This strategic move is expected to enhance Fineotex’s market position in the specialty chemicals sector, particularly in the oilfield segment, potentially offering new growth opportunities and strengthening its international presence.

Fineotex Chemical Limited Strengthens Growth Prospects with Successful Warrant Exercise
Dec 1, 2025

Fineotex Chemical Limited has successfully exercised warrants on a preferential basis, with significant participation from its promoter group, indicating strong confidence in the company’s growth prospects. The funds raised will be used for working capital and potential acquisitions, bolstering Fineotex’s expansion plans and reinforcing its market position both domestically and internationally.

Fineotex Chemical Expands Capital Through Warrant Conversion
Nov 21, 2025

Fineotex Chemical Limited has announced the allotment of 13,750,000 equity shares following the conversion of warrants, as approved in their recent board meeting. This move, conducted on a preferential basis, increases the company’s issued and paid-up capital to Rs. 115,95,00,900, reflecting strategic financial maneuvering to strengthen its market position and shareholder value.

Fineotex Chemical Limited Schedules Earnings Conference Call for Q2 FY2025-26
Nov 12, 2025

Fineotex Chemical Limited has announced an upcoming earnings conference call scheduled for November 18, 2025, to discuss its operational and financial performance for the second quarter and first half of the fiscal year 2025-26. This call will provide insights into the company’s performance and strategic direction, potentially impacting investor confidence and market positioning.

Fineotex Chemical Limited Conducts EGM via Video Conferencing
Oct 25, 2025

Fineotex Chemical Limited held an Extraordinary General Meeting (EGM) on October 25, 2025, via video conferencing, in compliance with the relevant provisions and circulars issued by the Ministry of Corporate Affairs and SEBI. The meeting was attended by key directors and members, including the Chairman and Managing Director, Surendrakumar Tibrewala, and other executive and non-executive directors, with a total of 50 members participating. The EGM proceedings were conducted to ensure adherence to regulatory requirements and to facilitate the company’s operational and strategic discussions.

Fineotex Chemical Limited Approves Share Capital Increase at EGM
Oct 25, 2025

Fineotex Chemical Limited held an Extraordinary General Meeting (EGM) on October 25, 2025, where all proposed resolutions were addressed. The meeting was conducted via video conferencing, and shareholders were provided with remote e-voting facilities. The primary resolution involved approving an increase in authorized share capital, which was passed without any opposition from the promoter group. The scrutinizer’s report confirmed the voting results, indicating strong shareholder support for the resolution.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 07, 2025